Bausch Health is rumored to be looking to sell its Bausch + Lomb business, which will ease bankruptcy concerns and upgrade ...

Bausch + Lomb has a pretty solid balance sheet that hasn’t changed a lot in the last few quarters. Read why I remain bullish ...

Analyst Glen Santangelo of Jefferies reiterated a Buy rating on Bausch Health Companies (BHC – Research Report), reducing the price ...

In a report released yesterday, Larry Biegelsen from Wells Fargo assigned a Buy rating on Bausch + Lomb Corporation (BLCO – Research ...

Jefferies has maintained its Buy rating on Bausch & Lomb Corporation (NYSE ... Blink NutriTears, and Bausch + Lomb INFUSE contact lenses. In light of these results, the company raised its full-year ...

Jefferies has maintained its Buy rating on Bausch & Lomb Corporation ... Blink NutriTears, and Bausch + Lomb INFUSE contact lenses. In light of these results, the company raised its full-year ...

You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Bausch + Lomb is a member of the Zacks Medical Services industry. One other stock in the same industry ...

Bausch + Lomb stock surged Monday — briefly breaking out — on a report the company is working with advisors to explore a potential sale.

Company operates a contact lens manufacturing facility in Waterford where approximately 1,500 people are employed.

Consumer medical giant Bausch + Lomb may be preparing to sell off its eye care business, which would include contact lens ...

Contact Lens Supplier Bausch + Lomb Eyes Sale Amid Separation Challenges As Parent Bausch Health Faces Debt Issues Bausch + Lomb is exploring a sale as its parent company, Bausch Health ...